Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10699708 | 0.80 | USP2 (0.50) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL6282106 | 0.79 | PDE4A (0.56) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL28165325 | 0.79 | PDE4A (0.56) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL360335 | 0.79 | PDE4A (0.56) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL27496778 | 0.78 | PDE4A (0.54) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL3350436 | 0.77 | PDE4A (0.46) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Mannitol SCHEMBL21272731 | 0.76 | PDE4A (0.56) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL1347333 | 0.76 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL284554 | 0.76 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 | |
| Phosphoric Acid SCHEMBL1696409 | 0.76 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219437-A1 | METHOD FOR PRODUCING LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE USING CORYNEBACTERIUM GLUTAMICUM | (주)에이피테크놀로지 | 2023-11-16 | — | — | WO | claimed |
| CN-112458034-B | Recombinant escherichia coli constructed by genetic engineering and method for biologically synthesizing 6' -sialyllactose | 南开大学 | 2023-01-24 | — | — | CN | claimed |
| WO-2022213660-A1 | RECOMBINANT ESCHERICHIA COLI FOR PRODUCING HEPAROSAN AND USE THEREOF | 江南大学 | 2022-10-13 | — | — | WO | claimed |
| US-20210355520-A1 | METHOD FOR THE PRODUCTION OF AMINO SUGAR CONTAINING PRODUCTS | UNIVERSITEIT GENT (BE) | 2021-11-18 | — | — | US | claimed |
| EP-3853372-A1 | METHOD FOR THE PRODUCTION OF AMINO SUGAR CONTAINING PRODUCTS | Universiteit Gent (BE) | 2021-07-28 | — | — | EP | claimed |
| WO-2020058493-A1 | METHOD FOR THE PRODUCTION OF AMINO SUGAR CONTAINING PRODUCTS | UNIVERSITEIT GENT (BE) | 2020-03-26 | — | — | WO | claimed |
| EP-2350289-A1 | PLANTS WITH INCREASED YIELD (NUE) | BASF Plant Science GmbH (DE) | 2011-08-03 | — | — | EP | claimed |
| WO-2010046221-A1 | PLANTS WITH INCREASED YIELD (NUE) | BASF PLANT SCIENCE GMBH (DE) | 2010-04-29 | — | — | WO | claimed |
| US-20020064836-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-05-30 | — | — | US | claimed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260015636-A1 | ENHANCING FORMATION OF HUMAN MILK OLIGOSACCHARIDES (HMOS) BY MODIFYING LACTOSE IMPORT IN THE CELL | DSM IP ASSETS BV (DK) | 2026-01-15 | — | — | US | disclosed |
| US-20250361477-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | INBIOSE NV (BE) | 2025-11-27 | — | — | US | disclosed |
| US-20250295749-A1 | INACTIVATED STAPHYLOCOCCUS COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | BIOLOGICAL MIMETICS INC (US) | 2025-09-25 | — | — | US | disclosed |
| US-20250188504-A1 | PRODUCTION OF A MIXTURE OF MAMMALIAN MILK OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| US-20050181388-A1 | Novel purified polypeptides from bacteria | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2005-08-18 | — | — | US | disclosed |
| US-20040091976-A1 | Process and materials for production of glucosamine and N-acetylglucosamine | ARKION LIFE SCIENCES LLC D/B/A BIO-TECHNICAL RESOURCES DIVISION | 2004-05-13 | — | — | US | disclosed |
| WO-2004003175-A2 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | ARKION LIFE SCIENCES LLC (US) | 2004-01-08 | — | — | WO | disclosed |
| US-6534648-B1 | Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2003-03-18 | — | — | US | disclosed |
| US-6444654-B1 | Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response | BOARD OF REGENTS OF UNIVERSITY OF NEBRASKA | 2002-09-03 | — | — | US | disclosed |
| US-6172220-B1 | Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis | BOARD OF REGENTS OF UNIVERSITY OF NEBRASKA | 2001-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015636-A1 | ENHANCING FORMATION OF HUMAN MILK OLIGOSACCHARIDES (HMOS) BY MODIFYING LACTOSE IMPORT IN THE CELL | GALNT2, GALNT1, GALNT10 | USP2 3618/4885SLCO1B1 74/4885LMNA 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.